Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
Go back to Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity| (NASDAQ: BMEA) | Delayed: 1.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.23 | 52 Week High | $ | |||
| Open | $1.23 | 52 Week Low | $ | |||
| Day High | $1.23 | P/E | N/A | |||
| Day Low | $1.23 | EPS | $ | |||
| Volume | 173 | |||||
